Return on investment from childhood immunization in low- and middle-income countries, 2011-20

Sachiko Ozawa, Samantha Clark, Allison Portnoy, Simrun Grewal, Logan Brenzel, Damian G. Walker

Research output: Contribution to journalArticle

Abstract

An analysis of return on investment can help policy makers support, optimize, and advocate for the expansion of immunization programs in the world's poorest countries. We assessed the return on investment associated with achieving projected coverage levels for vaccinations to prevent diseases related to ten antigens in ninety-four low- and middle-income countries during 2011-20, the Decade of Vaccines. We derived these estimates by using costs of vaccines, supply chains, and service delivery and their associated economic benefits. Based on the costs of illnesses averted, we estimated that projected immunizations will yield a net return about 16 times greater than costs over the decade (uncertainty range: 10-25). Using a full-income approach, which quantifies the value that people place on living longer and healthier lives, we found that net returns amounted to 44 times the costs (uncertainty range: 27-67). Across all antigens, net returns were greater than costs. But to realize the substantial positive return on investment from immunization programs, it is essential that governments and donors provide the requisite investments.

Original languageEnglish (US)
Pages (from-to)199-207
Number of pages9
JournalHealth Affairs
Volume35
Issue number2
DOIs
StatePublished - Jan 1 2016

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Return on investment from childhood immunization in low- and middle-income countries, 2011-20'. Together they form a unique fingerprint.

  • Cite this

    Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G. (2016). Return on investment from childhood immunization in low- and middle-income countries, 2011-20. Health Affairs, 35(2), 199-207. https://doi.org/10.1377/hlthaff.2015.1086